Technology for modulating autoimmunity expands intellectual property portfolio
Recommendation to Advance to Increased Dose in Third and Final Cohort of Phase 1 Portion of Trial Indicates Favorable Safety Profile of Novel Gene Therapy in Solid Tumor Cancer
Corporate Presentation to Highlight Company's Gene Therapies for Cancer and Diabetes
Designed and Secured by Barsec